Login / Signup

Is concurrent intravenous alteplase in patients undergoing endovascular treatment for large vessel occlusion stroke cost-effective even if the cost of alteplase is only US$1?

Johanna Maria OspelRosalie McDonoughWolfgang Gerhard KunzMayank Goyal
Published in: Journal of neurointerventional surgery (2021)
EVT without concurrent alteplase is the preferred strategy from a health economic standpoint.
Keyphrases
  • endovascular treatment
  • acute ischemic stroke
  • patients undergoing
  • locally advanced
  • public health
  • healthcare
  • atrial fibrillation
  • high dose
  • health information
  • radiation therapy
  • rectal cancer
  • social media